Global Insights From The World Leader in Serving Science

The biotech and pharma industry landscape is evolving at an incredible pace. The increasing push for patient-centric medicine, the rapid growth of innovative technologies such as artificial intelligence and predictive modeling, as well as ever-changing governmental regulations around taxation and approvals, all require today’s pharma organizations to be more agile, acquire new technologies and
identify new business models to compete.

Join Thermo Fisher Scientific President and Chief Executive Officer, Marc Casper, and Michel Lagarde, Senior Vice President and President, Pharma Services, for an intimate and deep discussion about common challenges faced by small and emerging biopharma and the strategies to overcome them.